SIGNIA Therapeutics laureate of i-Lab 2017 award

We are very proud to announce that Signia Therapeutics is laureate of the i-Lab 2017 award from the French Ministry of Higher Education, Research and Innovation, and BpiFrance.

The i-Lab is a national competition open to all French start-ups designed to identify the most promising technical innovations by France’s most forward-thinking start-ups. The award is associated with a grant aimed at helping laureates to bring their innovation to the market.


More informations: